These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4052954)

  • 21. Natural killing in normal children and children with Hodgkin's disease.
    Kamiya H; Starr S; Lange B
    Am J Pediatr Hematol Oncol; 1985; 7(4):389-92. PubMed ID: 4083399
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphoid irradiation results in long-term increases in natural killer cells in patients treated for Hodgkin's disease.
    Macklis RM; Mauch PM; Burakoff SJ; Smith BR
    Cancer; 1992 Feb; 69(3):778-83. PubMed ID: 1730127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressed spontaneous natural killing and interferon augmentation in patients with malignant lymphoma.
    Hawrylowicz CM; Rees RC; Hancock BW; Potter CW
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1081-8. PubMed ID: 6891651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.
    Manzano L; Alvarez-Mon M; Abreu L; Antonio Vargas J; de la Morena E; Corugedo F; Duràntez A
    Gut; 1992 Feb; 33(2):246-51. PubMed ID: 1541421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Natural cytotoxicity in patients with Hodgkin's disease].
    Frydecka I; Budzyński W; Kuliczkowski K; Rybczyńska H
    Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1309-12. PubMed ID: 6609349
    [No Abstract]   [Full Text] [Related]  

  • 26. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH
    Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Hodgkin's lymphoma: natural cell-mediated cytotoxicity correlated with histological classification and prognosis.
    Mehta B; Advani S; Nadkarni J
    Oncology; 1989; 46(5):323-5. PubMed ID: 2779947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytotoxicity of effector cells of the peripheral blood, lymph nodes and spleen in Hodgkin's disease].
    Blokhina NG; Bykovskaia SN; Kharabadze MV; Kupriianova TA; Agafonov VA
    Biull Eksp Biol Med; 1989 Nov; 108(11):600-3. PubMed ID: 2633827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cell activity in Hodgkin's disease patients undergoing radiation therapy or chemotherapy and radiation therapy.
    Pinel MI; Esteves EB; Rumjanek VM
    Clin Lab Haematol; 1998 Oct; 20(5):303-6. PubMed ID: 9807678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma.
    Metha BA; Advani SH; Nadkarni SJ
    Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin's disease in different phases of the disease.
    Frydecka I; Kaczmarek P; Boćko D; Kosmaczewska A; Morilla R; Catovsky D
    Leuk Lymphoma; 1999 Nov; 35(5-6):545-54. PubMed ID: 10609792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer cell deficiency associated with Hodgkin's lymphoma: a case report.
    Yang CM; Yang YH; Lin YT; Lu MY; Chiang BL
    J Formos Med Assoc; 2002 Jan; 101(1):73-5. PubMed ID: 11911042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immune monitoring of the cancer patient: suppressor cells and NK cells].
    Goutner A; Thomas Y; Huchet R; Mathé G
    C R Seances Soc Biol Fil; 1980; 174(4):750-5. PubMed ID: 6159953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte-induced human natural killer cell suppression followed by increased cytotoxic activity during short-term in vitro culture in autologous serum.
    Jondal M; Merrill J; Ullberg M
    Scand J Immunol; 1981 Nov; 14(5):555-63. PubMed ID: 7336174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection.
    Ramana Rao PV; Rajasekaran S; Raja A
    AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1435-43. PubMed ID: 19000024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequently relapsing minimal change nephrotic syndrome with natural killer cell deficiency prior to the overt relapse of Hodgkin's disease.
    Mori T; Yabuhara A; Nakayama J; Kitahara M; Washizawa K; Kasai S; Komiyama A
    Pediatr Nephrol; 1995 Oct; 9(5):619-20. PubMed ID: 8580025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assessment of natural cell-mediated cytotoxicity in patients with malignant lymphoma.
    Healy F; Rees RC; Hancock BW
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):775-83. PubMed ID: 2412830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
    Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
    Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.